Skip to main content
Skip to navigation
Print subscriptions
Sign in
Search jobs
Search
International edition
International edition
UK edition
US edition
Australia edition
Europe edition
The Guardian - Back to home
The Guardian
News
Opinion
Sport
Culture
Lifestyle
Show
More
Show More
News
View all News
World news
UK news
Climate crisis
Ukraine
Environment
Science
Global development
Football
Tech
Business
Obituaries
Opinion
View all Opinion
The Guardian view
Columnists
Cartoons
Opinion videos
Letters
Sport
View all Sport
Olympics 2024
Football
Cricket
Rugby union
Tennis
Cycling
F1
Golf
US sports
Culture
View all Culture
Books
Music
TV & radio
Art & design
Film
Games
Classical
Stage
Lifestyle
View all Lifestyle
Fashion
Food
Recipes
Love & sex
Health & fitness
Home & garden
Women
Men
Family
Travel
Money
Search input
google-search
Search
Support us
Print subscriptions
International edition
UK edition
US edition
Australia edition
Europe edition
Search jobs
Holidays
Digital Archive
Guardian Licensing
About Us
The Guardian app
Video
Podcasts
Pictures
Newsletters
Today's paper
Inside the Guardian
The Observer
Guardian Weekly
Crosswords
Wordiply
Corrections
Search jobs
Holidays
Digital Archive
Guardian Licensing
About Us
Pfizer
February 2024
Drug to treat alopecia recommended for NHS use for first time
Ritlecitinib, taken once a day, approved by Nice for severe hair loss caused by autoimmune disease
January 2024
Observer business profile
‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution
Will weight loss drugs kill the fast food business?
December 2023
‘It wouldn’t exist’: Viagra inventor tells how Welsh miners began its rise
Texas lawsuit claims Pfizer exaggerated effectiveness of Covid vaccine
October 2023
Soaring congenital syphilis rates in US risk lives of thousands of babies
Biden administration urged to declare a public health emergency with key medication for preventable condition in short supply
September 2023
DeSantis backs Florida surgeon general in urging residents against new Covid vaccines
Democrats say deaths will follow false claim by Dr Joseph Ladapo that new boosters were not tested on humans
August 2023
Covid booster jabs could go on sale privately in UK in 2024
Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65
July 2023
‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare
Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest
April 2023
AstraZeneca overtakes Pfizer as crunch week for UK pharma looms
Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results
February 2023
Observer business profile
Pfizer’s Susan Rienow: from Covid to fighting the ‘silent pandemic’
The pharma giant’s UK chief is adding the company’s voice to scientists’ warnings of the dangers of antibacterial resistance
January 2023
Biden will announce end of national and public health Covid emergencies in May
US moves to simplify Covid vaccines into yearly dose to target variants
November 2022
New Covid variants are circulating. What do we know and will the Omicron-specific booster be effective?
WHO says the strains are not different enough to label them variants of concern but experts urge staying up to date with vaccines
October 2022
Vaccines to treat cancer possible by 2030, say BioNTech founders
Uğur Şahin and Özlem Türeci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells
August 2022
Moderna sues Pfizer and BioNTech over coronavirus vaccine
Company is suing pharmaceutical rival and its German partner for patent infringement
July 2022
Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug
Penalties come after an in-depth investigation carried out by the Competition and Markets Authority
Watchdog reprimands EU executive for failing to share Von der Leyen texts
European Commission ‘gave no good reason’ why its president’s messages with Pfizer were not released
Pfizer vaccines that target Omicron variant pass first step to approval in Australia
The TGA’s ‘provisional determination’ for two vaccines comes as BA.4 and BA.5 subvariants drive new wave of Covid cases
May 2022
Pfizer to offer all its drugs not-for-profit to 45 lower-income countries
Company launches ‘healthier world’ accord in Davos and speaks to other pharma firms about similar steps
About 523 results for Pfizer
1
2
3
4
...
Explore more on these topics
Pharmaceuticals industry
Coronavirus
Vaccines and immunisation
Health (Australia news)
Infectious diseases